Abstract
Objective To assess the safety and efficacy of endoscopic retrograde cholangiopancreatography (ERCP) for children with pancreaticobiliary diseases. Methods Data of children under 14 years old who have underwent ERCP in Nanjing Drum Tower Hospital between September 2007 and August 2016 were reviewed for completion, complications and therapeutic methods. Results A total of 41 children underwent 68 ERCP, including 6(8.8%) diagnostic and 62(91.2%) therapeutic procedures. All procedures were performed under deep sedation. Cannulation failed in only 1 child with anomalous junction of pancreaticobiliary duct. The procedure success rate was 98.5%(67/68). There were 8 adverse events, including 7 mild post-ERCP pancreatitis and 1 fever. Incidence of adverse event was 11.8%(8/68). There was no such severe adverse event as bleeding, perforation, death, or other anesthesia related adverse event. Thirty-two children (78.0%) had follow-up, ranging from 2 month to 6 years. Children followed lived well with no long-term adverse event. Conclusion ERCP is an effective and safe procedure for the diagnosis and treatment of pancreaticobiliary diseases in children. Key words: Child; Endoscopic retrograde cholangiopancreatography; Diagnosis; Therapeutic endoscopy; Pancreaticobiliary diseases
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.